The importance of urinary tract infection (UTI) in patients with spinal cord injury cannot be understated. Many patients with signi®cant bacteriuria are considered to be colonised rather than infected, and treatment should be reserved for those with clinical symptoms or other signs of infection.
Introduction
Urinary tract infection remains a major cause of morbidity in patients with spinal cord injury 4 although with improved management mortality from urinary sepsis is reducing. 5 The normal human bladder is inherently resistant to infection through a number of defence mechanisms and the development of UTI therefore depends upon the balance between bacterial virulence and host defences. 6 Host defences include the mechanical eect of¯ushing the urine; cell mediated immunity; local production of immunoglobulin in the bladder wall and the mucous lining of the bladder also oers a protective eect. When host defences are seriously compromised by defective bladder emptying or by the presence of a urinary catheter, vesicoureteric re¯ux or stones then the individual is likely to be susceptible to virtually any organisms that can invade the urinary tract, irrespective of the presence or absence of any bacterial virulence factors. 6 The formation of bacterial bio®lms containing aggregates of micro-organisms in the bladders of spinal cord injured patients who require catheterisation may explain why infection, once established, is often persistent and apparently resistant to antibiotics. 7 The presence or absence of symptoms may be a poor guide to the damaging eect of bacteriuria on the bladder epithelium. 8 UTI most commonly results from ascending transurethral invasion of the bladder by pathogenic organisms normally present in the gut. Ascending infection is preceded by colonisation of the introitus or periurethral area or migration of bacteria within the urinary collection system.
Bladder drainage
Correct management of the bladder in the early stages following spinal cord injury is particularly important. Preservation of renal function is the ultimate goal and the choice of bladder drainage is particularly important in reducing the incidence of UTI. 9, 10 Ideally the patient is appliance free but the use of indwelling catheterisation may be necessary. The incidence of bacteriuria in the patient with a longterm indwelling catheter (ie 428 days) is high and has been reported as approximately 98% 11, 12 and mixed populations of bacteria are frequently isolated. 13 Bacteriuria is associated with both acute and chronic Spinal Cord (1997) 35, 198 ± 204 complications including bacteraemia, acute pyelonephritis, bladder and renal stones, vesicoureteric re¯ux, chronic interstitial nephritis, renal failure and death. 12, 14 Indwelling catheters should therefore be used for as short a time as possible and consideration should be given to the use of intermittent or ®ne bore supra-pubic catheterisation or condom drainage as these methods appear to be associated with lower rates of bacteriuria 15 ± 17 and fewer complications. 18 Other procedures which facilitate adequate bladder emptying may be used eg surgery to relieve urinary out¯ow obstruction, the use of electrostimulation, re¯ex voiding or pharmacological agents acting on the bladder or its sphincters. Low residual volumes are associated with lower rates of UTI. 19 Close urological follow-up at a specialist centre is essential to maintain satisfactory bladder and renal function and prevent complications.
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Catheter care and infection control
The importance of hygienic catheter care using a closed drainage system, 22 hand hygiene, sta and patient education has been well recognised as being important in preventing UTI. 23 In addition the team approach to bladder management has been highlighted. 24 Table 1 summarises the recommendations for prevention of catheter-associated UTI.
In spinal cord injury centres there is often widespread contamination of the environment with gram negative bacilli which are often multi-resistant. Sanderson and Rawal found extensive contamination of the patients environment with the same organism which had previously been isolated from the patients' urine. 25 Environmental contamination was found in face cloths, clothing, wheelchairs and on bedside lockers. Contamination of the hands of sta and patients can therefore readily occur and lead to crossinfection. 26, 27 The importance of hand-washing as a primary infection control measure in preventing crossinfection has been emphasised and re-emphasised by several workers in the last century. 28 
Choice of catheter
There has been recent interest in the development of catheter materials which would prevent encrustation and the formation of bio®lms. However Ramsey and colleagues reported encrustation and the development of bio®lms on all types of catheter materials routinely used including plastic, latex, te¯on-coated latex and silicone. 29 Roberts et al in an in vitro study reported that bacterial adherence to hydrophilic coated latex catheters did not occur and recommended their use. 30 Other types of catheters which have also been investigated include a lubricating catheter (into which a mixture of methyl cellulose and polymixin B is inserted); vented catheters; silver oxide-coated catheters and catheters impregnated with antiseptics or antibiotics. 31 None of these have been adopted for routine use although research continues into the dierent catheter designs.
The use of topical antiseptics
Patients with spinal cord injury soon develop colonisation with gram negative bacilli. Fawcett et al showed that the perineum, groins, penile shafts and urethras were heavily colonised by a range of multiply resistant gram negative bacilli which started to colonise 2 ± 3 days after admission. 32 They also found that the same species of bacteria could be demonstrated colonising the skin prior to the development of UTI. It is desirable therefore to attempt to ensure that the external meatus around the catheter is kept clean and free from encrustation. 33 The use of topical antiseptics (eg chlorhexidine or silver sulphadiazine) applied to the perineal area and/ or urethra prior to catheterisation has proved disappointing in preventing bacteriuria, although widely practised. 34, 35 Equally the use of medicated soap, 32, 36 and antiperspirants 37 has been unsuccessful in preventing bacterial colonisation. It would be reasonable however to promote cleanliness and local hygiene by daily perineal washing with soap and water. The removal of an external urinary collection system at night time has been shown to reduce urethral colonisation with Pseudomonas but not with Klebsiella but has no eect on the incidence of bacteriuria. 
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Antiseptic solution in drainage bags
The use of antiseptics in catheter drainage bags to prevent bacteriuria has also been reported. In vitro studies have indicated that a formaldehyde preparation may be eective. 39 In vivo studies with chlorhexidine have however proved disappointing. 40 Hydrogen peroxide seems of bene®t in those requiring short term drainage only. 41 Giroux and Perkash, however, found hydrogen peroxide unsatisfactory when used for leg bags in patients with spinal cord injury as the gas released (as a result of the breakdown of the hydrogen peroxide) caused in¯ation of the drainage bag with subsequent impairment of drainage. 42 In addition they reported that povidoneiodine although apparently eective in vitro was not successful in vivo in preventing bacteriuria. Also some patients developed iodine allergy and the discolouration of the drainage bag made it dicult to make a visual assessment of the state of the urine. They recommended the use of 0.06% sodium hypochlorite for the surface disinfection of the urinary drainage bag and 6% household bleach to clean re-usable bags (followed by thorough rinsing with water). 9 
Bladder washouts or instillations
The use of bladder washouts or instillations with a variety of substances has also been recommended to prevent the formation of debris and stones and to prevent and control infections. Suby-G solution (containing citric acid 3.25%) twice weekly has been advocated by some workers to help prevent encrustation of the catheter especially in the early weeks following spinal cord injury when hypercalciuria may occur. 43 A number of antiseptic and antibiotic solutions have been suggested for instillation into the bladder after intermittent catheterisation. Haldorson and colleagues however, reported no bene®t in using neomycin instillations as they did not reduce the incidence of bacteriuria. 44 Pearman et al. later suggested that Trisdine (chlorhexidine 0.01% with EDTA) was preferable to use than kanamycin/colistin as it was more stable at room temperature, less likely to select antibiotic resistant bacteria and less expensive. 45 There has been some success reported with the prophylactic use of chlorhexidine bladder washouts in patients undergoing short term catheterisation. However many workers have reported chlorhexidine resistance in bacteria isolated from the urine of catheterised patients. 46 There has also been little success in using antiseptic bladder washouts in treating established infection in patients requiring long-term indwelling catheterisation. 47, 48 Stickler and co-workers studied antiseptic resistance in their Unit. They found noxythiolin to have poor clinical activity and approximately 10% of their urinary isolates showed resistance to cationic antiseptics (chlorhexidine, cetrimide and benzalkonium chloride). 48, 49 Their more recent work using a bladder model suggested that mandelic acid (1%) may be useful as a bladder washout. 50 The use of bladder washouts or instillations is not without problems. There is an increased risk of infection from frequently breaking the closed drainage system; the problem of bacterial resistance; chemical cystitis may occur and mechanical damage to the bladder (from disruption of the mucosal cells and damage to the protecting mucous layer) may facilitate bacterial invasion into deeper mucosal layers. 51 For those patients with long-term indwelling catheters it is likely that the physical eects of a washout may be more important than the action of any local antiseptic especially in controlling the formation of debris.
Oral antiseptic, acidifying and alkalinising agents
Oral antiseptic, acidifying or alkalinising agents are often used in patients with spinal cord injury. Methenamine salts (mandelate and hippurate) are antiseptics which have been widely used. They act by releasing formaldehyde in an acid urine. This has theoretical advantages as bacterial resistance to formaldehyde does not develop, there is no eect on the bowel¯ora and it is relatively inexpensive.
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Kevorkian et al. reported that methenamine mandelate (given with ammonium chloride for acidi®cation) was an eective prophylactic agent and signi®cantly reduced the incidence of UTI in patients with neurogenic bladders. 54 Krebs and co-workers found oral methenamine with bladder instillations of hemiacridin (to acidify the urine) were eective in reducing the incidence of bacteriuria in patients undergoing intermittent catheterisation. 52 There is no consensus of opinion on the use of ascorbic acid as an acidifying agent. 55 McDonald and Murphy reported that ascorbic acid was superior to methionine in acidifying the urine of catheterised patients. 56 Nickey studied the eect of giving subjects cranberry juice and ascorbic acid (alone or in combination), on urinary pH. 57 He found that essentially the same degree of mean lowering of pH occurred when these were used alone or in combination. Others however, have reported that ascorbic acid was not an eective urinary acidi®er 58 or eective in preventing UTI. 59 Pearman and England equally did not ®nd ascorbic acid useful and recommended ammonium chloride or methionine as acidifying agents for their patients. 53 Grundy and Russell recommended the use of ascorbic acid or hexamine (methenamine hippurate) for use in patients with spinal injury with recurrent urinary tract infections. 60 Alkalinising agents eg sodium bicarbonate, oral citrate, and acetazolamide have also been used. The activity of aminoglycoside antibiotics (eg gentamicin) is increased in alkaline urine and these agents have been recommended for patients receiving treatment. Unfortunately, the use of alkalinising agents is likely to predispose to the formation of debris or urinary
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A Galloway stones and is contraindicated in patients with poor renal function. The eectiveness of acidifying or alkalinising agents is, however, in¯uenced by diet and needs to be taken into consideration when managing the individual patient. 61 
Prophylactic antibiotics
In the catheterised patient the prophylactic use of antibiotics reduces the incidence of bacteriuria initially and success has been reported using trimethoprim, sulphamethoxazole or nitrofurantoin; 62 ampicillin; 63 nor¯oxacin 64 and cipro¯oxacin. 65 Studies on the long term ecacy of prophylactic antibiotics have, however, shown no bene®t either in reducing the rate of bacteriuria, 66 or symptoms. 67, 68 Their use in a patient with an indwelling catheter is, therefore, not generally recommended. 10, 35, 69 The use of prophylactic antibiotics for patients receiving intermittent catheterisation is controversial. Thorsteinsson and Keys reported no success in preventing infection for patients receiving trimethoprim-sulphamethoxazole. 70 Similarly Kuhlemeier et al. found no bene®t in the use of trimethoprimsulphamethoxazole, nalidixidic acid, methenamine hippurate or nitrofurantoin. 59 Others have found that irrespective of the method of bladder drainage prophylactic trimethoprim-sulphamethoxazole does not reduce the incidence of symptomatic UTI but does increase the incidence of resistant isolates in asymptomatic patients. 71, 72 Reid et al. reported that prophylactic trimethoprim-sulphamethoxazole was not eective in preventing UTI but found that ciprofloxacin was particularly able to penetrate adherent bio®lms and suggested it may be an appropriate agent to use. 7 Biering-Sorenson and colleagues also found cipro¯oxacin to be a useful prophylactic agent. 73 Some workers have found nitrofurantoin useful in preventing UTI. 74 ± 76 Linden and Joiner however, considered Pseudomonas aeruginosa as a coloniser and not a`uropathogen' and dismissed its signi®cance. 75 Pseudomonas aeruginosa cannot however always be assumed to be harmless as in one study it was found to be the commonest organism associated with symptomatic UTI in patients with spinal cord injury. 77 In certain circumstances the use of prophylactic antibiotics needs to be considered. It has been suggested for those who have recurrent UTIs and a dilated upper urinary tract. Three months prophylaxis has been recommended if infection persists after treatment of any established infection and other conditions which would promote recurrent infections eg calculi or bladder out¯ow obstruction. 78 The threat of emerging resistant bacteria, risk of unwanted side eects of antibiotics, unnecessary expense and the potential risk to other patients from cross-infection with multiply resistant bacteria are all good reasons why the use of antibiotics should be used with extreme caution in patients with spinal cord injury. 79 
Experimental methods of prevention
A number of other approaches to the prevention of recurrent UTIs have also been explored. There are a variety of ways by which bacterial adherence may be inhibited. First, the use of vaccination. The results in humans generally appear to be disappointing as there is wide antigenic variation among gram negative bacilli causing recurrent infection. 80 Research, however, continues and recent work with animal models suggests there may be some success in using a vaccine containing Proteus outer membrane protein 81 or a polyvalent vaccine containing the bacteria most frequently causing UTI ±`SolcoUrovac'. 82 Secondly, there has also been limited success in using receptor analogues with galactosea1-galactoseb containing structures in preventing adhesion as the potential ecacy depends on the frequency of gala1-galb recognising bacteria in the population studied. 80, 83 Thirdly, the instillation of a mucopolysaccharide into the bladder (similar to the naturally occurring glycosaminoglycan which normally protects the uroepithelium) has been suggested. 76 The use of bacterial interference has gained interest recently. There has been some success in treating women with recurrent UTIs by using vaginal pessaries of lactobacilli in an attempt to colonise the perineum and urethra with normal¯ora. 84 Hagberg and colleagues have had some success with instillations of E. coli showing no recognised virulence factors (isolated from a patient with asymptomatic bacteriuria), in preventing symptomatic infection with patho- 85 Immunotherapy with orally administered extracts from E. coli has also been reported to be eective in reducing the incidence of urinary tract infections in paraplegic patients. 86 
Conclusions
There are a number of approaches to prevention of UTI in patients with spinal cord injury. Expert urological management is essential. Following this microbiological preventive methods start to play a role ( Table 2 ). Antiseptics and antibiotics can be used in a variety of ways but should be used with caution as resistance can readily develop, making serious infections dicult to treat. 55 Research into dierent methods of prevention of UTI needs to continue. 87 In particular it would be useful to look into greater detail as to which patients would bene®t from antiseptics, antibiotics or immunotherapy. The use of multi-centre trials would allow sucient numbers of patients to be readily evaluated. Other approaches to prevention also need to be explored and should be encouraged. In terms of the microbiological aspects of prevention of UTI plenty has been done but there is still a lot more that can be achieved. 24 
